GB1289096A - - Google Patents

Info

Publication number
GB1289096A
GB1289096A GB1289096DA GB1289096A GB 1289096 A GB1289096 A GB 1289096A GB 1289096D A GB1289096D A GB 1289096DA GB 1289096 A GB1289096 A GB 1289096A
Authority
GB
United Kingdom
Prior art keywords
compositions
oct
treatment
acid
absorptionpromoting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1289096A publication Critical patent/GB1289096A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
GB1289096D 1968-10-03 1968-10-03 Expired GB1289096A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4704268 1968-10-03

Publications (1)

Publication Number Publication Date
GB1289096A true GB1289096A (de) 1972-09-13

Family

ID=10443490

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1289096D Expired GB1289096A (de) 1968-10-03 1968-10-03

Country Status (1)

Country Link
GB (1) GB1289096A (de)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007691B1 (de) * 1978-07-31 1984-01-18 Massachusetts Institute Of Technology Zusammensetzungen zur Verwendung bei der Verminderung des Appetites auf Kohlenhydratkalorien
GB2157561A (en) * 1984-03-20 1985-10-30 Egyt Gyogyszervegyeszeti Gyar An injectable solution especially for treating ketosis
WO1987001590A1 (en) * 1985-09-20 1987-03-26 Stephen Neil Kreitzman A composition and pack for use in the treatment of obesity
DE3912232A1 (de) * 1989-04-11 1989-11-30 Klosa Josef Mittel gegen harninkontinenz
WO2008006485A1 (de) * 2006-07-13 2008-01-17 Beiersdorf Ag Kosmetische oder dermatologische zubereitungen mit einem gehalt an folsäure und einem oder mehreren polyolen
EP2269649A3 (de) * 2004-08-26 2011-08-10 Merz Pharma GmbH & Co. KGaA Ein Kapillar-Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007691B1 (de) * 1978-07-31 1984-01-18 Massachusetts Institute Of Technology Zusammensetzungen zur Verwendung bei der Verminderung des Appetites auf Kohlenhydratkalorien
GB2157561A (en) * 1984-03-20 1985-10-30 Egyt Gyogyszervegyeszeti Gyar An injectable solution especially for treating ketosis
WO1987001590A1 (en) * 1985-09-20 1987-03-26 Stephen Neil Kreitzman A composition and pack for use in the treatment of obesity
DE3912232A1 (de) * 1989-04-11 1989-11-30 Klosa Josef Mittel gegen harninkontinenz
EP2269649A3 (de) * 2004-08-26 2011-08-10 Merz Pharma GmbH & Co. KGaA Ein Kapillar-Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung
WO2008006485A1 (de) * 2006-07-13 2008-01-17 Beiersdorf Ag Kosmetische oder dermatologische zubereitungen mit einem gehalt an folsäure und einem oder mehreren polyolen

Similar Documents

Publication Publication Date Title
HU175537B (hu) Sposob poluchenija novykh farmakologicheski aktivnykh proizvodnykh pirimidona s geterociklicheskim substituentom v bokovojj cepi
GB1289096A (de)
CA973554A (en) 2,3,5,6-tetraaminopyridine and its acid salts and processes for its preparation
ES2000536A6 (es) Un procedimiento para la preparacion de nuevos compuestos de b-lactama
GB1491503A (en) Method of preventing and treating thrombosis
ES419506A1 (es) Un procedimiento para la preparacion de nuevos acidos (1- oxo-2, 3-hidrocarbilen-5-indaniloxi) alcanoico.
GB1202148A (en) Pharmaceutical compositions
GB1477624A (en) Amino acid parenteral solution containing reducing sugar
ES8203349A1 (es) Un procedimiento para la preparacion de 1,2-bis(nicotinami- do) propano
AU3678371A (en) l-(3-CYANO-3, 3, DIPHENYLPROPYL)-4-PEHNYLPIP ERINE-4-CARBOXYLIC ACID DERIVATIVES
GB1446584A (en) Agent for deodorising and influencing perspiration
GB1261989A (en) 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same
GB1187946A (en) Dimethylbiguanide Derivative
GB1054698A (de)
GB1181967A (en) Novel Picoline Derivatives and a Method for the Production Thereof
ES8203086A1 (es) Un procedimiento para la produccion de n,n'-bis-(3-picolil) -4-metoxi-isoftalamida monohidratada
GB1246727A (en) Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids
GB1535778A (en) Compounds useful in treatment of unipolar depression
GB1357813A (en) Effervescent composition for the treatment of heart diseases
GB1195294A (en) Improvements in or relating to Pharmaceutical Compositions
GB1187546A (en) Propanolamine derivatives
ES369304A1 (es) Procedimiento de preparacion de nuevos derivados nitrogena-dos de la metil-2 benzil-3 imidazo-3h (4,5-b) piridina.
GB1111433A (en) A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions
ES8105284A1 (es) Procedimiento para preparar indolinas.
GB1250279A (de)

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years